Half of millennials and 75% of Gen Zers have left their job for mental health reasons

Cases of burnout have been increasing at an alarming rate in recent years among millennials and Gen Zers. It’s a growing problem in today’s workplace because due to rising workloads, limited staff and resources and long hours.

GM sweetens UAW contract offer with $7.7 billion in direct US factory investment

GM says its latest offer to striking UAW members addresses the union’s top concerns, also including preserving health care.

NASA chief: SpaceX and Boeing have critical tests ahead but could fly astronauts in early 2020

SpaceX and Boeing are each in the final stages of developing the spacecraft needed for the U.S. to once again fly astronauts.

Cramer’s lightning round: MGM’s gambling and sports plans are ‘spectacular’

Jim Cramer takes calls and opines on viewer stock picks of the day in rapid speed.

Wendy’s CEO to Jim Cramer: ‘We have a menu that can compete’ in breakfast

“We have a menu that can compete, a low-investment and a high-return model for our franchise community,” CEO Todd Penegor says of Wendy’s breakfast strategy.

Cramer’s week ahead: It is shaping up to be a good week for earnings

“I’m expecting many of these quarters could be better than expected,” “Mad Money’s” Jim Cramer says.

Judge rules Trump violated the law on wall funding with national emergency

A federal judge ruled Friday that President Donald Trump violated federal law when he used his declaration of a national emergency to get millions for building a wall on the southern border.

Boeing CEO loses chairman role to focus on 737 Max crisis

Boeing’s board removed CEO Dennis Muilenburg as chairman amid the fall out of two 737 Max crashes that killed 346 people.

Retail legend Mickey Drexler on how clothing companies can succeed in today’s environment

“You don’t need huge assortments to shop anymore … Focus on the best,” former J. Crew CEO Mickey Drexler says.

FDA approves new Eli Lilly drug to ‘resolve’ migraine pain in two hours

The U.S. Food and Drug Administration approved a drug to help prevent migraines on Thursday. The drug, Reyvow, was developed by Eli Lilly and Co. and has proven effective in alleviating the painful symptoms of migraines.